Purification of recombinant human phosphodiesterase 7A expressed in Dictyostelium discoideum

Protein Expression and Purification

Volumn 61, Issue 2, 2008, Pages 149-154

  Arya, Ranjana ^a   Gupta, Shivani ^b   Aslam, Saima ^a   Kaur, Namrata Jit ^b   Seth, Aayush ^b   Eapen, Mathew S ^b   Malik, Renu ^b   Vijayakrishnan, Lalitha ^b   Saini, Kulvinder Singh ^b  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b RANBAXY LABORATORIES LTD   (India)

Author keywords

Dictyostelium discoideum; PDE7A; Phosphodiesterase; Purification; Recombinant protein expression

Indexed keywords

CYCLIC AMP; PDE7A PROTEIN, HUMAN; PHOSPHODIESTERASE VII; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; CYTOLOGY; DICTYOSTELIUM; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVATION; GENE EXPRESSION; GENE VECTOR; HUMAN; ISOLATION AND PURIFICATION; KINETICS; METABOLISM; MOLECULAR CLONING;

ANIMALS; CELLS, CULTURED; CLONING, MOLECULAR; CYCLIC AMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 7; DICTYOSTELIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC VECTORS; HUMANS; KINETICS; RECOMBINANT PROTEINS;

DICTYOSTELIUM DISCOIDEUM; MAMMALIA;

EID: 50249184702     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2008.05.002     Document Type: Article

References (23)

1. Lugnier C. Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. Pharmacol. Ther. 109 (2006) 366-398
2. Houslay M.D., Schafer P., and Zhang K.Y. Phosphodiesterase-4 as a therapeutic target. Drug Discov. Today 10 (2003) 1503-1519
3. Torphy T.J. Phosphodiesterase isozymes: molecular targets for novel antiasthma agents. Am. J. Respir. Crit. Care Med. 157 (1998) 351-370
4. Dastidar S.G., Rajagopal D., and Ray A. Therapeutic benefit of PDE4 inhibitors in inflammatory diseases. Curr. Opin. Invest. Drugs 8 (2007) 364-372
5. Vijayakrishnan L., Rudra S., Eapen M.S., Dastidar M.S., and Ray A. Small-molecule inhibitors of PDE-IV and -VII in the treatment of respiratory diseases and chronic inflammation. Expert. Opin. Invest. Drugs 16 (2007) 1585-1599
6. Giembycz M.A., and Smith S.J. Phosphodiesterase 7A a new therapeutic target for alleviating chronic inflammation?. Curr. Pharm. Des. 12 (2006) 3207-3220
7. Jones N.A., Leport M., Holand T., Vos T., Morgan M., Fink M., Pruniaux M.P., Berthelier C., O'Connor B.J., Bertrand C., and Page C.P. Phosphodiesterase (PDE) 7 in inflammatory cells from patients with asthma and COPD. Pulm. Pharmacol. Ther. 20 (2007) 60-68
8. Bender A.T., and Beavo J.A. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol. Rev. 58 (2006) 488-520
9. Michaeli T., Bloom T.J., Martins T., Loughney K., Ferguson K., Riggs M., Rodgers L., Beavo J.A., and Wigler M. Isolation and characterization of a previously undetected human cAMP phosphodiesterase by complementation of cAMP phosphodiesterase-deficient Saccharomyces cerevisiae. J. Biol. Chem. 268 (1993) 12925-12932
10. Li L., Yee C., and Beavo J.A. CD3 and CD28 dependent induction of PDE7 required for T cell activation. Science 283 (1999) 848-851
11. Yang G., McIntyre K.W., Townsend R.M., Shen H.N., Pitts W.J., Dodd J.H., Nadler S.G., McKinnon M., and Watson A.J. Phosphodiesterase 7A-deficient mice have functional T cells. J. Immunol. 171 (2003) 6414-6420
12. + T-lymphocytes. Mol. Pharmacol. 66 (2004) 1679-1689
13. Yamamoto S., Sugahara S., Ikeda K., and Shimizu Y. Amelioration of collagen-induced arthritis in mice by a novel phosphodiesterase 7 and 4 dual inhibitor YM-393059. Eur. J. Pharmacol. 559 (2007) 219-226
14. Richter W., Hermsdorf T., Kronbach T., and Dettmer D. Refolding and purification of recombinant human PDE7A expressed in Escherichia coli as inclusion bodies. Protein Expr. Purif. 25 (2002) 138-148
15. Dittrich W., Williams K.L., and Slade M.B. Production and secretion of recombinant proteins in Dictyostelium discoideum. Nat. Biotechnol. 12 (1994) 614-618
16. Voith G., and Dingermann T. Expression of the human muscarinic receptor gene m2 in Dictyostelium discoideum. Biotechnology (NY), 13 (1995) 1225-1229
17. Malik R., Bora R.S., Gupta D., Sharma P., Arya R., Choudhary S., and Saini K.S. Cloning, Stable expression of human phosphodiesterase 7A and development of an assay for screening of PDE7 selective inhibitors. Appl. Microbiol. Biotechnol. 77 (2008) 1167-1173
18. Arya R., Aslam S., Gupta S., Bora R.S., Vijayakrishnan L., Gulati P., Naithani S., Mukherjee S., Dastidar S., Bhattacharya A., and Saini K.S. Production and characterization of pharmacologically active recombinant human phosphodiesterase 4B2 in Dictyostelium discoideum. Biotechnol. J. (2008) 10.1002/biot.200700256
19. Wang P., Wu P., Egan R.W., and Billah M.M. Cloning characterization and tissue distribution of mouse phosphodiesterase 7A1. Biochem. Biophys. Res. Commun. 276 (2000) 1271-1277
20. Hetman J.M., Soderling S.H., Glavas N.A., and Beavo J.A. Cloning and characterization of PDE7B a cAMP-specific phosphodiesterase. Proc. Natl. Acad. Sci. USA (2000) 472-476
21. Sahdev S., Khattar S.K., and Saini K.S. Production of active eukaryotic proteins through bacterial expression systems: a review of the existing biotechnology strategies. Mol. Cell. Biochem. 307 (2008) 249-264
22. Salanova M., Jin S.C., and Conti M. Heterologous expression and purification of recombinant rolipram-sensitive cyclic AMP-specific phosphodiesterases. Methods. 14 (1998) 55-64
23. Bora R.S., Malik R., Arya R., Gupta D., Singh V., Agarwal N., Dastidar S., Ray A., and Saini K.S. A reporter gene assay for screening of PDE4 subtype selective inhibitors. Biochem. Biophys. Res. Commun. 356 (2007) 153-158